End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.93 NZD | +1.03% | -2.33% | -16.29% |
05-01 | AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV | MT |
04-24 | New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.29% | 183M | |
+32.95% | 700B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B | |
-1.81% | 157B |
- Stock Market
- Equities
- AFT Stock
- News AFT Pharmaceuticals Limited
- AFT Pharmaceuticals Secures Australia, New Zealand License for Epilepsy Rescue Medication